8-K ·Filed May 1, 2026

HAE

HAEMONETICS CORP
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0000313143-26-000023
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

No immediate trading implications. Monitor for any future board composition changes or strategic shifts, but this individual departure is routine.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
HAE ▲ +54.41% at T+60d
NEUTRAL call ✓ call won +54.41% · α vs SPY +52.55% · entry $55.32 → $85.42
Entry anchored
May 1, 2026
via day open
T+1d
+0.54%
call +0.54% · α -0.25%
$55.62
settled 5mo ago
T+5d
-5.57%
call -5.57% · α -8.50%
$52.24
settled 5mo ago
T+20d
+21.51%
call +21.51% · α +15.87%
$67.22
settled 4mo ago
T+60d
+54.41%
call +54.41% · α +52.55%
$85.42
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Director Charles J. Dockendorff will not stand for re-election at Haemonetics' 2026 annual meeting, continuing to serve until then. His departure is not due to any disagreement with the company, making this a routine board transition with no expected impact on operations or strategy.

Key Facts

  • Charles J. Dockendorff informed the company on April 27, 2026 that he will not stand for re-election at the 2026 annual meeting.
  • Dockendorff has served as a director since 2014 and remains a member of the Audit and Governance/Compliance Committees until the meeting.
  • The decision is explicitly stated as not resulting from any disagreement with Haemonetics.

Financial Impact

No financial impact; routine director departure.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000313143-26-000023
Document: 0000313143-26-000023-index-headers.html0000313143-26-000023
Document: 0000313143-26-000023-index.html0000313143-26-000023
Document: 0000313143-26-000023.txt0000313143-26-000023
5 reports for HAE
Performance horizon
Filters
Rows
Reports for HAE — sortable, filterable
TypeNow
Aug 18, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$104.65 $105.68▲ +0.98%▲ +1.97%$104.68 (+0.03%)
Jun 9, 2026
16w ago
DEFA14A
NEUTRAL ★ 5/10
$78.80 $75.00▼ −4.82%▼ −8.45%$104.68 (+32.84%)
Jun 5, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$71.28 $75.02▲ +5.25%▲ +3.39%$104.68 (+46.86%)
May 7, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$54.37 $65.88▲ +21.17%▲ +18.03%$104.68 (+92.53%)
May 1, 2026
22w ago
8-K
NEUTRAL ★ 2/10
$55.32 $67.22▲ +21.51%▲ +15.87%$104.68 (+89.23%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (64h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access